Enhanced sensing for digital health

The 21st century has brought a number of completely new healthcare challenges: increasing numbers of chronic diseases, including cancer, COPD, asthma, and diabetes in an aging population; and broad changes to both environment and lifestyle that amplify the occurrence, consequences and cost of such diseases.

Digital health infrastructure recently received a major push forward to address these healthcare challenges. It not only automatizes sharing patient data, accessing sites of care and simplifying the payment flow. It will also further empower patients in everyday life to monitor their own health from their homes, get their drugs administered without a healthcare provider required to be present, and obtain feedback on drug delivery and the course of the disease. Such functions are implemented and enabled by portable, wearable and interactive devices that use sensors to monitor the patient.

Sensirion is actively supporting this developing ecosystem with sensors built to address these needs: measuring patient air flow, drug flow and patient breath gases. As this journey has only just begun, we are working to extend the technologies and sensors offered in digital health.

To find out more about Sensirion’s solutions, visit them at Booth H19 in Hall 8A at this year’s COMPAMED in Düsseldorf –

Post a comment

Your email address will not be published. Required fields are marked *

Recent News

Globus Medical obtains FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System

Successful completion of the inaugural shoulder arthroplasty surgeries utilizing Stryker’s Blueprint® Mixed Reality Guidance System occurred at Mayo Clinic in Minnesota and St. Joseph’s Health Care in London, Canada.

Medical Device Technologies Market is projected to increase from USD 4.20 Billion in 2022 to USD 16.32 Billion by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 18.50% over the forecast period

Hodess Cleanroom Construction expands its cleanroom services capabilities with the acquisitions of Protocol Management Services and Clean Rooms West

Medtronic Will Invest Up to $75 Million And begin Co-Promotion For CathWorks’ FFRangio System In The U.S. Europe and Japan

Tornier Shoulder Arthroplasty Portfolio Introduced by Stryker, With New Tornier Perform Humeral System Launched in Europe